PentaBind Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.16M

  • Investors
  • 10

PentaBind General Information

Description

Developer of precision aptamer therapeutics intended to treat unmet diseases. The company uses artificial intelligence and an integrated wet laboratory to design aptamers that can be used to detect and target almost any molecule of interest, enabling the biotechnology industry to develop new products and services for precision medicine, therapeutic design, and continuous monitoring.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Scale Space, 58 Woodlane
  • White City
  • London W12 7RZ
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Scale Space, 58 Woodlane
  • White City
  • London W12 7RZ
  • England, United Kingdom

PentaBind Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PentaBind Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Early Stage VC 19-Jun-2025 $1.16M Completed Pre-Clinical Trials
9. Accelerator/Incubator 01-Feb-2025 Completed Pre-Clinical Trials
8. Seed Round 15-Oct-2024 Completed Pre-Clinical Trials
7. Accelerator/Incubator 01-Jan-2024 Completed Pre-Clinical Trials
6. Accelerator/Incubator 14-Sep-2023 Completed Pre-Clinical Trials
5. Angel (individual) 09-Jan-2023 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
2. Accelerator/Incubator 24-Mar-2022 $114K $114K Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view PentaBind’s complete valuation and funding history, request access »

PentaBind Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed Preferred
A Ordinary
Seed Preferred
A Ordinary
A Ordinary
A Ordinary 93,300 $0.000100 $1.29 $1.29 1x $1.29 5.85%
A Ordinary 6,438 $0.000100 $9.78 $9.78 1x $9.78 0.4%
To view PentaBind’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PentaBind Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PentaBind Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hoxton Ventures Venture Capital Minority
Grow London Accelerator/Incubator
Next Sequence Accelerator/Incubator Minority
Twin Path Ventures Venture Capital Minority
BioIndustry Association Accelerator/Incubator
You’re viewing 5 of 10 investors. Get the full list »

PentaBind FAQs

  • When was PentaBind founded?

    PentaBind was founded in 2021.

  • Where is PentaBind headquartered?

    PentaBind is headquartered in London, United Kingdom.

  • What is the size of PentaBind?

    PentaBind has 14 total employees.

  • What industry is PentaBind in?

    PentaBind’s primary industry is Drug Discovery.

  • Is PentaBind a private or public company?

    PentaBind is a Private company.

  • What is the current valuation of PentaBind?

    The current valuation of PentaBind is .

  • What is PentaBind’s current revenue?

    The current revenue for PentaBind is .

  • How much funding has PentaBind raised over time?

    PentaBind has raised $2.48M.

  • Who are PentaBind’s investors?

    Hoxton Ventures, Grow London, Next Sequence, Twin Path Ventures, and BioIndustry Association are 5 of 10 investors who have invested in PentaBind.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process